Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Is Tissue Cross-Talk Important in Cancer Cachexia?

Volumen 17, Edición 3, 2012, pp. 263-276
DOI: 10.1615/CritRevOncog.v17.i3.40
Get accessGet access

SINOPSIS

Recent work suggests molecular cross-talk between adipose tissue and muscle that occurs through adipokines and myokines. These molecules act in an endocrine fashion to play an intricate role in regulating body composition in both health and disease. Studies in exercise physiology have focused on the molecular cross-talk between adipose tissue and muscle that occurs through adipokines and myokines and on the role these molecules may play in chronic diseases. Similarly, integrative physiology in obesity and diabetes has long emphasised the importance of chronic inflammation, increased adipocyte lipolysis, and increased levels of circulating free fatty acids in the adipose-muscle cross-talk that contributes to lipotoxicity and insulin resistance in muscle. Cachexia affects the majority of patients with advanced cancer and is associated with a reduction in treatment tolerance, response to therapy, quality of life, and duration of survival. Although cachexia in patients with cancer is characterized by systemic inflammation, increased lipolysis, insulin resistance, and reduced physical activity, there has been little effort to manipulate the integrative physiology of adipose tissue and muscle tissue for therapeutic gain.

CITADO POR
  1. Johns N., Stephens N.A., Fearon K.C.H., Muscle wasting in cancer, The International Journal of Biochemistry & Cell Biology, 45, 10, 2013. Crossref

  2. Martin Lena, Lagergren Pernilla, Risk Factors for Weight Loss Among Patients Surviving 5 Years After Esophageal Cancer Surgery, Annals of Surgical Oncology, 22, 2, 2015. Crossref

  3. Morishita Shinichiro, Tsubaki Atsuhiro, Fu Jack B., Physical Therapy in Patients with Cancer, in Frailty and Sarcopenia - Onset, Development and Clinical Challenges, 2017. Crossref

  4. Vaitkus Janina A, Celi Francesco S, The role of adipose tissue in cancer-associated cachexia, Experimental Biology and Medicine, 242, 5, 2017. Crossref

  5. Schink Kristin, Herrmann Hans J., Schwappacher Raphaela, Meyer Julia, Orlemann Till, Waldmann Elisabeth, Wullich Bernd, Kahlmeyer Andreas, Fietkau Rainer, Lubgan Dorota, Beckmann Matthias W., Hack Carolin, Kemmler Wolfgang, Siebler Jürgen, Neurath Markus F., Zopf Yurdagül, Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial, BMC Cancer, 18, 1, 2018. Crossref

  6. Boura Paraskevi, Loukides Stylianos, Grapsa Dimitra, Achimastos Apostolos, Syrigos Konstantinos, The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives, Future Oncology, 11, 15, 2015. Crossref

  7. Gortan Cappellari Gianluca, Brasacchio Caterina, Laudisio Daniela, Lubrano Carla, Pivari Francesca, Barrea Luigi, Muscogiuri Giovanna, Savastano Silvia, Colao Annamaria, Sarcopenic obesity: What about in the cancer setting?, Nutrition, 98, 2022. Crossref

  8. Twining Peter K., Groot Olivier Q., Buckless Colleen G., Kapoor Neal D., Bongers Michiel E. R., Janssen Stein J., Schwab Joseph H., Torriani Martin, Bredella Miriam A., Body Composition Predictors of Adverse Postoperative Events in Patients Undergoing Surgery for Long Bone Metastases, JAAOS: Global Research and Reviews, 6, 3, 2022. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain